Elliot Stieglitz MD
Pediatric Hematologic Oncology
Associate Professor
Request appointment
HDFCCC Stieglitz Lab1450 3rd St, Room 283San Francisco, CA 94158
Overview of Dr. Stieglitz
Dr. Elliot Stieglitz is a pediatric hematologist/oncologist in San Francisco, CA and is affiliated with UCSF Medical Center. He received his medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 18 years. He is one of 72 doctors at UCSF Medical Center who specialize in Pediatric Hematology & Oncology. He also speaks multiple languages, including Spanish. He has more than 70 publications and over 500 citings.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2011 - 2014
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2008 - 2011
Stony Brook University Health Sciences Center School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2011 - 2028
NY State Medical License 2009 - 2012
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- K08 Clinical Investigator Award NHLBI @ NIH, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2015-2017
Clinical Trials
Publications & Presentations
PubMed
- Ribonucleotide Reductase Inhibition Overcomes FLT3 Inhibitor Resistance in Acute Myeloid Leukemia.Zhen Tian, Xiaoyu Wei, Srinivas Chatla, Yang Liu, Dongwook Kim
Biorxiv. 2026-07-22 - HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL.Kevin O McNerney, Soyang Kwon, Swati Naik, Vanessa A Fabrizio, Gabriela Llaurador Caraballo
Blood Advances. 2026-07-17 - Therapeutic Targeting of IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation in Juvenile Myelomonocytic Leukemia.Santhosh Kumar Pasupuleti, Baskar Ramdas, Kanaka Sai Ram Padam, Rahul Kanumuri, Lakshmi Reddy Palam
Blood. 2026-06-02
Journal Articles
- Downregulating Notch Counteracts KrasG12D-Induced ERK Activation and Oxidative Phosphorylation in Myeloproliferative NeoplasmErik A Ranheim, David Yang, Warren S Pear, Lan Zhou, Mignon Loh, Eric Padron, Elliot Stieglitz, Nature
Abstracts/Posters
- DNA Methylation As a Biomarker of Outcome in JMML: An International Effort Towards Clinical ImplementationElliot Stieglitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell MalignanciesElliot Stieglitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Promising New Combination of Drugs Identified to Treat Juvenile Myelomonocytic LeukemiaApril 7th, 2023
Baby Diagnosed with Rare Blood Cancer Saved by Miracle TreatmentSeptember 26th, 2019
Infant with Deadly Leukemia Saved by Drug for Adult Liver CancerSeptember 12th, 2019
Grant Support
- Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia.UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
Other Languages
- Spanish
External Links
- LinkedInhttp://www.linkedin.com/pub/elliot-stieglitz/20/384/870
- Stieglitz Labhttps://www.stieglitzlab.com
- ElliotStieglitz.comhttp://www.elliotstieglitz.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
